Clinical Trials

Multiple Myeloma

NCT03201965 2025-11-26

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

416 enrolled 28 charts 5 FDA

Amyloidosis

NCT06022939 2025-09-15

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Phase 3 Recruiting

338 enrolled

Phase 3 Active not recruiting

Immunoglobulin Light-chain Amyloidosis

NCT00734877 2025-06-29

TT4B

382 enrolled

Multiple Myeloma

NCT01539083 2025-02-04

VCAT

256 enrolled 13 charts

Multiple Myeloma

NCT01093196 2024-11-07

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

660 enrolled

Disease, Multiple Myeloma

NCT01091831 2024-11-06

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

389 enrolled

Multiple Myeloma

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Phase 3 Recruiting

99 enrolled

Multiple Myeloma

NCT03440411 2021-03-10

PO-3887

Phase 3 Terminated

9 enrolled 20 charts

Multiple Myeloma

NCT01146834 2019-12-27

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

47 enrolled 12 charts

Multiple Myeloma

NCT01554852 2018-06-11

Myeloma XI

4,420 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03402295 2018-01-18

GBRAM003r

311 enrolled

Multiple Myeloma

NCT00083915 2017-11-20

DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation

97 enrolled 7 charts

Multiple Myeloma

NCT02248428 2017-09-06

CTd

130 enrolled

Multiple Myeloma

NCT02362165 2016-04-20

CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

236 enrolled

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

668 enrolled 7 charts

Multiple Myeloma, Neoplasms

NCT01971658 2015-10-07

IFM2013-04

358 enrolled

Multiple Myeloma

NCT00002548 2015-03-06

SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

899 enrolled

Multiple Myeloma

NCT00005834 2015-03-06

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

Phase 3 Terminated

19 enrolled

Multiple Myeloma

NCT00813150 2014-08-15

Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma

96 enrolled 12 charts

Multiple Myeloma, Neoplasms

NCT00002599 2013-12-19

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

750 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002653 2013-12-19

Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma

1,000 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00003603 2013-09-20

Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

660 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00028886 2013-09-17

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

450 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00747877 2013-08-12

High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

460 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002556 2013-05-31

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

312 enrolled

Multiple Myeloma

NCT00004230 2012-06-06

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

35 enrolled

Teratoma, Testicular, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT01532856 2012-02-15

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

64 enrolled

Multiple Myeloma

NCT01070862 2010-02-18

MAG 2002

Multiple Myeloma

NCT00002989 2009-02-09

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome